GB2548424A — Liquid pharmaceutical composition of clonidine
Assigned to Syri Ltd · Expires 2017-09-20 · 9y expired
What this patent protects
A liquid pharmaceutical composition is disclosed, suitable for oral administration, comprising clonidine or pharmaceutically acceptable salts thereof with at least one buffer and at least one preservative. Also disclosed is a process for preparing the said liquid pharmaceutical c…
USPTO Abstract
A liquid pharmaceutical composition is disclosed, suitable for oral administration, comprising clonidine or pharmaceutically acceptable salts thereof with at least one buffer and at least one preservative. Also disclosed is a process for preparing the said liquid pharmaceutical composition. The composition finds particular use in paediatric and geriatric patients and in having enhanced dose uniformity which helps minimise medication error and overdose.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.